mesalamine has been researched along with Disbacteriosis in 8 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ulcerative colitis is an inflammatory bowel disease that forms ulcerations in the mucous membrane of the colon and rectum, in which gut microbiota plays a pivotal role in its pathogenesis." | 1.72 | Therapeutic Potential of Metabolites from ( Aljofan, M; Babenko, D; Chulenbayeva, L; Gulyayev, A; Kozhakhmetov, S; Kozhakhmetova, S; Kushugulova, A; Muhanbetganov, N; Nurgaziyev, M; Nurgozhina, A; Sergazy, S; Tuyakova, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozhakhmetov, S | 1 |
| Babenko, D | 1 |
| Kozhakhmetova, S | 1 |
| Tuyakova, A | 1 |
| Nurgaziyev, M | 1 |
| Nurgozhina, A | 1 |
| Muhanbetganov, N | 1 |
| Chulenbayeva, L | 1 |
| Sergazy, S | 1 |
| Gulyayev, A | 1 |
| Aljofan, M | 1 |
| Kushugulova, A | 1 |
| Mei, X | 1 |
| Mell, B | 1 |
| Manandhar, I | 1 |
| Aryal, S | 1 |
| Tummala, R | 1 |
| Kyoung, J | 1 |
| Yang, T | 1 |
| Joe, B | 1 |
| Jun, X | 1 |
| Ning, C | 1 |
| Yang, S | 1 |
| Zhe, W | 1 |
| Na, W | 1 |
| Yifan, Z | 1 |
| Xinhua, R | 1 |
| Yulan, L | 1 |
| Lee, JY | 2 |
| Cevallos, SA | 2 |
| Byndloss, MX | 2 |
| Tiffany, CR | 2 |
| Olsan, EE | 2 |
| Butler, BP | 1 |
| Young, BM | 1 |
| Rogers, AWL | 1 |
| Nguyen, H | 2 |
| Kim, K | 1 |
| Choi, SW | 1 |
| Bae, E | 1 |
| Lee, JH | 1 |
| Min, UG | 1 |
| Lee, DC | 1 |
| Bäumler, AJ | 2 |
| Collins, M | 1 |
| DeWitt, M | 1 |
| Velazquez, EM | 1 |
| Foegeding, NJ | 1 |
| Shelton, CD | 1 |
| Parry, BH | 1 |
| Stull-Lane, AR | 1 |
| Savage, HP | 1 |
| Ghanaat, SS | 1 |
| Byndloss, AJ | 1 |
| Agu, IO | 1 |
| Tsolis, RM | 1 |
| Motta, JP | 1 |
| Allain, T | 1 |
| Green-Harrison, LE | 1 |
| Groves, RA | 1 |
| Feener, T | 1 |
| Ramay, H | 1 |
| Beck, PL | 1 |
| Lewis, IA | 1 |
| Wallace, JL | 1 |
| Buret, AG | 1 |
| Eun, CS | 1 |
| Kwak, MJ | 1 |
| Han, DS | 1 |
| Lee, AR | 1 |
| Park, DI | 1 |
| Yang, SK | 1 |
| Kim, YS | 1 |
| Kim, JF | 1 |
1 review available for mesalamine and Disbacteriosis
| Article | Year |
|---|---|
Fecal microbiota transplantation in the treatment of Crohn disease.
Topics: Costs and Cost Analysis; Crohn Disease; Dysbiosis; Fecal Microbiota Transplantation; Female; Gastroi | 2020 |
7 other studies available for mesalamine and Disbacteriosis
| Article | Year |
|---|---|
Therapeutic Potential of Metabolites from
Topics: Animals; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Gastroi | 2022 |
Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension.
Topics: Animals; Drug Delivery Systems; Drug Repositioning; Dysbiosis; Hypertension; Inflammatory Bowel Dise | 2022 |
Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
Topics: Adult; Colitis, Ulcerative; DNA, Fungal; Dysbiosis; Feces; Female; Fungi; Gastrointestinal Tract; Hu | 2020 |
High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Diet, High-Fat; Dysbiosis; | 2020 |
5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cytochrome b Group; Dextran Sulfat | 2021 |
Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
Topics: Adult; Animals; Bacterial Physiological Phenomena; Biofilms; Case-Control Studies; Disease Models, A | 2018 |
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
Topics: Acidobacteria; Actinobacteria; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathio | 2016 |